Singapore Medical Group Ltd
SGX:5OT
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| SG |
|
Singapore Medical Group Ltd
SGX:5OT
|
192.2m SGD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.4B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
71.2B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.1B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.4B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD |
Loading...
|
Market Distribution
| Min | -1 390 526.2% |
| 30th Percentile | 14.7% |
| Median | 28.1% |
| 70th Percentile | 43.4% |
| Max | 515 258.2% |
Other Profitability Ratios
Singapore Medical Group Ltd
Glance View
Singapore Medical Group Ltd. is an investment holding company, which engages in the management of medical clinics; and provision of general medical services. The company employs 296 full-time employees The company went IPO on 2009-07-23. The Company’s Health, Diagnostic & Aesthetics and Others. The Health segment comprises obstetrical and gynecological services; oncology services, including the prevention, diagnosis and treatment of cancer, cancer screening and cancer genetic and risk assessment; pediatrics services; general medicine and health screening services; cardiology services, and endocrinology services. The Diagnostic & Aesthetics segment comprises radiology and diagnostic imaging services; refractive surgery services; dental services including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment and aesthetics medicine services that offer healthcare services related to physical appearances. The Others segment comprises group-level corporate services as well as business consultancy functions and telemedicine services.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Singapore Medical Group Ltd’s Gross Margin has decreased from 44.9% to 42.3%. During this period, it reached a low of 42.3% on Jun 30, 2022 and a high of 45.7% on Dec 31, 2019.
